News | October 24, 2007

Speakers to Address Tumor Immunology, Biological Therapy

October 25, 2007 - The “Primer on Tumor Immunology and Biological Therapy” will be held on Thursday, Nov. 1, 2007 in Boston and feature several prominent speakers in the field of cancer research.

The educational program, developed by the International Society for Biological Therapy of Cancer, is organized by Martin A Cheever M.D. of the Fred Hutchinson Cancer Research Group and Kim A. Margolin, M.D. of the City of Hope Cancer Center. The primer’s presenters will provide a current overview of immunology and biological therapy regarding clinical applications for the treatment of cancer and address the current underpinnings of biological therapy and tumor immunology.

Participants include scientists working in industry, post-doctoral fellows, graduate students, practicing physicians and research technicians in the field of cancer research. Many attendees have substantial background in one specialized area of biological therapy or tumor immunology, but often have little or no familiarity with other areas. It is the goal of the Primer to help educate attendees in these other fields of study and practice.

This year’s audience will learn central concepts and recent advances in cancer vaccines, vaccine adjuvants, host-tumor interactions, the role of “danger” signals in integrating innate and adaptive immunity, T cell therapy, angiogenesis, antibody therapy and cytokines.

The complete listing of this year’s speakers includes:

Judah Folkman, M.D. – Children’s Hospital Boston
Patrick Hwu, MD – M.D. Anderson Cancer Center
Rakesh K. Jain, Ph.D. – Harvard Medical School
Kim A. Margolin, M.D. – City of Hope Cancer Center
Francesco Marincola, M.D. – National Institutes of Health
Polly Matzinger, Ph.D. – National Institutes of Allergy and Infectious Diseases
Ira H. Pastan, M.D. – National Institutes of Health
Kenneth Rock, M.D. – University of Massachusetts
Carmen Scheibenbogen, M.D. – Institut for Med Immunologie
Paul M. Sondel, MD, Ph.D. – University of Wisconsin
Louis M. Weiner, M.D. – Fox Chase Cancer Center

For more information:

Related Content

FDA Approves Exablate Neuro for Tremor-Dominant Parkinson's Treatment
Technology | Focused Ultrasound Therapy | December 21, 2018
Insightec announced that the U.S. Food and Drug Administration (FDA) has approved an expansion of the indication of...
Videos | Radiation Oncology | November 06, 2018
Genomics can be used to assess a patient's radiosensitivity, which can be used to increase or decrease the radiation
News | Radiation Dose Management | September 24, 2018
AngioDynamics Inc. announced an agreement to acquire RadiaDyne, a privately held medical diagnostic and device company...
​ITN Celebrates World Cancer Day 2018
News | Radiation Oncology | February 01, 2018
World Cancer Day takes place annually on Feb.
MR-HIFU, ThermoDox, combination therapy, recurrent childhood tumors, Celsion, Children's National Health System, Phase I clinical study
News | Oncology Related Products | December 19, 2016
December 19, 2016 — Children’s National Health System and Celsion Corp.
News | Clinical Decision Support | October 27, 2016
October 27, 2016 — The National Comprehensive Cancer Network (NCCN) continues to build its library of appropriate use
contrast-enhanced ultrasound, CEUS, liver cancer, hepatocellular carcinoma, study, Advances in Contrast Ultrasound conference, ICUS
News | Ultrasound Imaging | September 12, 2016
September 12, 2016 — Tiny microbubbles are being used to more effectively...
cardio-oncology, echo strain assessment, echoinsight, epsilon

Epsilon's EchoInsight software helps analyze cardiac function by evaluating wall motion strain. 

Feature | Cardio-oncology | May 13, 2016 | Dave Fornell
Cardio-oncology is an emerging field that combines the expertise of both cardiology and oncology to assess and treat
Carestream, Clinical Collaboration Platform, Fox Valley Hematology & Oncology
News | Enterprise Imaging | April 20, 2016
Fox Valley Hematology & Oncology (Appleton, Wis.) implemented Carestream’s Vue for Clinical Collaboration Platform...